 | • レポートコード：D0804-14405 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、α-アドレナリン受容体拮抗薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。α-アドレナリン受容体拮抗薬の種類別市場規模（非選択的拮抗薬、選択的拮抗薬）、用途別市場規模（高血圧症、レイノー病、勃起不全）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bristol-Myers Squibb、Astra Zeneca、Novartis、Sanofi、Merck、GSK、Eli Lilly、Jhonson and Johnson、Bayer、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・α-アドレナリン受容体拮抗薬の北米市場（アメリカ、カナダ、メキシコ） ・α-アドレナリン受容体拮抗薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・α-アドレナリン受容体拮抗薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・α-アドレナリン受容体拮抗薬の南米市場（ブラジル、アルゼンチン） ・α-アドレナリン受容体拮抗薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非選択的拮抗薬、選択的拮抗薬 ・用途別分析：高血圧症、レイノー病、勃起不全 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global α-adrenoreceptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The α-adrenoreceptor Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
α-adrenoreceptor Antagonists market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, α-adrenoreceptor Antagonists market has been segmented into
Non-selective Antagonists
Selective Antagonists
By Application, α-adrenoreceptor Antagonists has been segmented into:
Hypertension
Raynaud’s Disease
Erectile Dysfunction
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global α-adrenoreceptor Antagonists market presented in the report. This section sheds light on the sales growth of different regional and country-level α-adrenoreceptor Antagonists markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global α-adrenoreceptor Antagonists market.
The report offers in-depth assessment of the growth and other aspects of the α-adrenoreceptor Antagonists market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and α-adrenoreceptor Antagonists Market Share Analysis
α-adrenoreceptor Antagonists competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, α-adrenoreceptor Antagonists sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the α-adrenoreceptor Antagonists sales, revenue and market share for each player covered in this report.
The major players covered in α-adrenoreceptor Antagonists are:
Pfizer
Bristol-Myers Squibb
Astra Zeneca
Novartis
Sanofi
Merck
GSK
Eli Lilly
Jhonson and Johnson
Bayer
Teva Pharmaceutical
Among other players domestic and global, α-adrenoreceptor Antagonists market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe α-adrenoreceptor Antagonists product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of α-adrenoreceptor Antagonists, with price, sales, revenue and global market share of α-adrenoreceptor Antagonists in 2018 and 2019.
Chapter 3, the α-adrenoreceptor Antagonists competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the α-adrenoreceptor Antagonists breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, α-adrenoreceptor Antagonists market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe α-adrenoreceptor Antagonists sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 α-adrenoreceptor Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global α-adrenoreceptor Antagonists Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Non-selective Antagonists
1.2.3 Selective Antagonists
1.3 Market Analysis by Application
1.3.1 Overview: Global α-adrenoreceptor Antagonists Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hypertension
1.3.3 Raynaud’s Disease
1.3.4 Erectile Dysfunction
1.4 Overview of Global α-adrenoreceptor Antagonists Market
1.4.1 Global α-adrenoreceptor Antagonists Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca SWOT Analysis
2.3.4 Astra Zeneca Product and Services
2.3.5 Astra Zeneca α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jhonson and Johnson
2.9.1 Jhonson and Johnson Details
2.9.2 Jhonson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jhonson and Johnson SWOT Analysis
2.9.4 Jhonson and Johnson Product and Services
2.9.5 Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical SWOT Analysis
2.11.4 Teva Pharmaceutical Product and Services
2.11.5 Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global α-adrenoreceptor Antagonists Sales and Market Share by Manufacturer (2018-2019)
3.2 Global α-adrenoreceptor Antagonists Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 α-adrenoreceptor Antagonists Manufacturer Market Share in 2019
3.3.2 Top 6 α-adrenoreceptor Antagonists Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Regions
4.1.1 Global α-adrenoreceptor Antagonists Sales and Market Share by Regions (2015-2020)
4.1.2 Global α-adrenoreceptor Antagonists Revenue and Market Share by Regions (2015-2020)
4.2 North America α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
4.3 Europe α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
4.5 South America α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Country
5.1.1 North America α-adrenoreceptor Antagonists Sales and Market Share by Country (2015-2020)
5.1.2 North America α-adrenoreceptor Antagonists Revenue and Market Share by Country (2015-2020)
5.2 United States α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
5.3 Canada α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
5.4 Mexico α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Country
6.1.1 Europe α-adrenoreceptor Antagonists Sales and Market Share by Country (2015-2020)
6.1.2 Europe α-adrenoreceptor Antagonists Revenue and Market Share by Country (2015-2020)
6.2 Germany α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
6.3 UK α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
6.4 France α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
6.5 Russia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
6.6 Italy α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific α-adrenoreceptor Antagonists Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific α-adrenoreceptor Antagonists Revenue and Market Share by Regions (2015-2020)
7.2 China α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7.3 Japan α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7.4 Korea α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7.5 India α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7.6 Southeast Asia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
7.7 Australia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Country
8.1.1 South America α-adrenoreceptor Antagonists Sales and Market Share by Country (2015-2020)
8.1.2 South America α-adrenoreceptor Antagonists Revenue and Market Share by Country (2015-2020)
8.2 Brazil α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
8.3 Argentina α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa α-adrenoreceptor Antagonists Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa α-adrenoreceptor Antagonists Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa α-adrenoreceptor Antagonists Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
9.3 Turkey α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
9.4 Egypt α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
9.5 South Africa α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global α-adrenoreceptor Antagonists Sales and Market Share by Type (2015-2020)
10.2 Global α-adrenoreceptor Antagonists Revenue and Market Share by Type (2015-2020)
10.3 Global α-adrenoreceptor Antagonists Price by Type (2015-2020)
11 Global α-adrenoreceptor Antagonists Market Segment by Application
11.1 Global α-adrenoreceptor Antagonists Sales Market Share by Application (2015-2020)
11.2 Global α-adrenoreceptor Antagonists Revenue Market Share by Application (2015-2020)
11.3 Global α-adrenoreceptor Antagonists Price by Application (2015-2020)
12 Market Forecast
12.1 Global α-adrenoreceptor Antagonists Sales, Revenue and Growth Rate (2021-2025)
12.2 α-adrenoreceptor Antagonists Market Forecast by Regions (2021-2025)
12.2.1 North America α-adrenoreceptor Antagonists Market Forecast (2021-2025)
12.2.2 Europe α-adrenoreceptor Antagonists Market Forecast (2021-2025)
12.2.3 Asia-Pacific α-adrenoreceptor Antagonists Market Forecast (2021-2025)
12.2.4 South America α-adrenoreceptor Antagonists Market Forecast (2021-2025)
12.2.5 Middle East & Africa α-adrenoreceptor Antagonists Market Forecast (2021-2025)
12.3 α-adrenoreceptor Antagonists Market Forecast by Type (2021-2025)
12.3.1 Global α-adrenoreceptor Antagonists Sales Forecast by Type (2021-2025)
12.3.2 Global α-adrenoreceptor Antagonists Market Share Forecast by Type (2021-2025)
12.4 α-adrenoreceptor Antagonists Market Forecast by Application (2021-2025)
12.4.1 Global α-adrenoreceptor Antagonists Sales Forecast by Application (2021-2025)
12.4.2 Global α-adrenoreceptor Antagonists Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global α-adrenoreceptor Antagonists Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of α-adrenoreceptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global α-adrenoreceptor Antagonists Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer α-adrenoreceptor Antagonists Major Business
Table 9. Pfizer α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer α-adrenoreceptor Antagonists Product and Services
Table 12. Pfizer α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb α-adrenoreceptor Antagonists Major Business
Table 15. Bristol-Myers Squibb α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb α-adrenoreceptor Antagonists Product and Services
Table 18. Bristol-Myers Squibb α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 20. Astra Zeneca α-adrenoreceptor Antagonists Major Business
Table 21. Astra Zeneca α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 22. Astra Zeneca SWOT Analysis
Table 23. Astra Zeneca α-adrenoreceptor Antagonists Product and Services
Table 24. Astra Zeneca α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis α-adrenoreceptor Antagonists Major Business
Table 27. Novartis α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis α-adrenoreceptor Antagonists Product and Services
Table 30. Novartis α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi α-adrenoreceptor Antagonists Major Business
Table 33. Sanofi α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi α-adrenoreceptor Antagonists Product and Services
Table 36. Sanofi α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck α-adrenoreceptor Antagonists Major Business
Table 39. Merck α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck α-adrenoreceptor Antagonists Product and Services
Table 42. Merck α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK α-adrenoreceptor Antagonists Major Business
Table 45. GSK α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK α-adrenoreceptor Antagonists Product and Services
Table 48. GSK α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly α-adrenoreceptor Antagonists Major Business
Table 51. Eli Lilly α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly α-adrenoreceptor Antagonists Product and Services
Table 54. Eli Lilly α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Jhonson and Johnson α-adrenoreceptor Antagonists Major Business
Table 57. Jhonson and Johnson α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 58. Jhonson and Johnson SWOT Analysis
Table 59. Jhonson and Johnson α-adrenoreceptor Antagonists Product and Services
Table 60. Jhonson and Johnson α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer α-adrenoreceptor Antagonists Major Business
Table 63. Bayer α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 64. Bayer SWOT Analysis
Table 65. Bayer α-adrenoreceptor Antagonists Product and Services
Table 66. Bayer α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical α-adrenoreceptor Antagonists Major Business
Table 69. Teva Pharmaceutical α-adrenoreceptor Antagonists Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical SWOT Analysis
Table 71. Teva Pharmaceutical α-adrenoreceptor Antagonists Product and Services
Table 72. Teva Pharmaceutical α-adrenoreceptor Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global α-adrenoreceptor Antagonists Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global α-adrenoreceptor Antagonists Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global α-adrenoreceptor Antagonists Sales by Regions (2015-2020) (K Units)
Table 76. Global α-adrenoreceptor Antagonists Sales Market Share by Regions (2015-2020)
Table 77. Global α-adrenoreceptor Antagonists Revenue by Regions (2015-2020) (USD Million)
Table 78. North America α-adrenoreceptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 79. North America α-adrenoreceptor Antagonists Sales Market Share by Countries (2015-2020)
Table 80. North America α-adrenoreceptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 81. North America α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 82. Europe α-adrenoreceptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 83. Europe α-adrenoreceptor Antagonists Sales Market Share by Countries (2015-2020)
Table 84. Europe α-adrenoreceptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific α-adrenoreceptor Antagonists Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific α-adrenoreceptor Antagonists Revenue by Regions (2015-2020) (USD Million)
Table 88. South America α-adrenoreceptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 89. South America α-adrenoreceptor Antagonists Sales Market Share by Countries (2015-2020)
Table 90. South America α-adrenoreceptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 91. South America α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa α-adrenoreceptor Antagonists Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa α-adrenoreceptor Antagonists Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa α-adrenoreceptor Antagonists Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020)
Table 96. Global α-adrenoreceptor Antagonists Sales by Type (2015-2020) (K Units)
Table 97. Global α-adrenoreceptor Antagonists Sales Share by Type (2015-2020)
Table 98. Global α-adrenoreceptor Antagonists Revenue by Type (2015-2020) (USD Million)
Table 99. Global α-adrenoreceptor Antagonists Revenue Share by Type (2015-2020)
Table 100. Global α-adrenoreceptor Antagonists Sales by Application (2015-2020) (K Units)
Table 101. Global α-adrenoreceptor Antagonists Sales Share by Application (2015-2020)
Table 102. Global α-adrenoreceptor Antagonists Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global α-adrenoreceptor Antagonists Market Share Forecast by Regions (2021-2025)
Table 104. Global α-adrenoreceptor Antagonists Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global α-adrenoreceptor Antagonists Market Share Forecast by Type (2021-2025)
Table 106. Global α-adrenoreceptor Antagonists Sales Forecast by Application (2021-2025)
Table 107. Global α-adrenoreceptor Antagonists Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. α-adrenoreceptor Antagonists Picture
Figure 2. Global Sales Market Share of α-adrenoreceptor Antagonists by Type in 2019
Figure 3. Non-selective Antagonists Picture
Figure 4. Selective Antagonists Picture
Figure 5. α-adrenoreceptor Antagonists Sales Market Share by Application in 2018
Figure 6. Hypertension Picture
Figure 7. Raynaud's Disease Picture
Figure 8. Erectile Dysfunction Picture
Figure 9. Global α-adrenoreceptor Antagonists Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey α-adrenoreceptor Antagonists Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global α-adrenoreceptor Antagonists Sales Market Share by Manufacturer in 2019
Figure 30. Global α-adrenoreceptor Antagonists Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 α-adrenoreceptor Antagonists Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 α-adrenoreceptor Antagonists Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global α-adrenoreceptor Antagonists Revenue Market Share by Regions (2015-2020)
Figure 37. Global α-adrenoreceptor Antagonists Revenue Market Share by Regions in 2018
Figure 38. North America α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
Figure 39. Europe α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
Figure 41. South America α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020)
Figure 43. North America α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America α-adrenoreceptor Antagonists Sales Market Share by Countries (2015-2020)
Figure 45. North America α-adrenoreceptor Antagonists Sales Market Share by Countries in 2018
Figure 46. North America α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America α-adrenoreceptor Antagonists Revenue Market Share by Countries in 2018
Figure 48. United States α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020)
Figure 53. Europe α-adrenoreceptor Antagonists Revenue Market Share by Countries in 2019
Figure 54. Germany α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific α-adrenoreceptor Antagonists Sales Market Share by Regions 2019
Figure 61. Asia-Pacific α-adrenoreceptor Antagonists Revenue Market Share by Regions 2019
Figure 62. China α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America α-adrenoreceptor Antagonists Sales Market Share by Countries in 2019
Figure 69. South America α-adrenoreceptor Antagonists Revenue Market Share by Countries in 2019
Figure 70. Brazil α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa α-adrenoreceptor Antagonists Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa α-adrenoreceptor Antagonists Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa α-adrenoreceptor Antagonists Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa α-adrenoreceptor Antagonists Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa α-adrenoreceptor Antagonists Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global α-adrenoreceptor Antagonists Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global α-adrenoreceptor Antagonists Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales α-adrenoreceptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales α-adrenoreceptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales α-adrenoreceptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales α-adrenoreceptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales α-adrenoreceptor Antagonists Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- アンジオテンシン受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angiotensin …
- αブロッカーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global α-blocker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The α-blocker market report provides a …
- アルファブロッカーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Alpha Blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha Blockers market report p…